Security key
142152107
Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI)
CUSIP: 142152107
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 282,066,647
- Total 13F shares
- 109,280,872
- Share change
- +109,194,872
- Total reported value
- $2,919,429,193
- Price per share
- $26.72
- Number of holders
- 115
- Value change
- +$2,917,131,273
- Number of buys
- 114
Report period
Q2 2025
Institutions
115
Top holders
10
CAI full security history
Newer quarter: Q3 2025
Caris Life Sciences, Inc. SEC filings
Caris Life Sciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 142152107
Recent filing periods:
Top shareholders of CAI - Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| David D. Halbert |
13D/G
|
— |
44%
|
124,906,296
|
$3,311,265,907 | $0 | 30 Jun 2025 | |
| TSSP Sub-Fund HoldCo LLC |
13D/G
3/4/5
|
Alan Waxman · Former 10% Owner |
8.8%
|
24,385,399
|
— | $0 | 30 Jun 2025 | |
| RIVERVIEW GROUP LLC |
13D/G
|
Millennium Management LLC |
1.3%
|
3,583,100
|
— | $0 | 17 Jun 2025 | |
| J H Whitney VI L P |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
20,256,615
|
— | — | 20 Jun 2025 | |
| ADAPT I Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
16,943,232
|
— | — | 20 Jun 2025 | |
| Laura I. Johansen |
3/4/5
|
Director |
—
class O/S missing
|
330,705
|
— | — | 17 Jun 2025 | |
| Jonathan Kenneth Charles Knowles |
3/4/5
|
Director |
—
class O/S missing
|
307,379
|
— | — | 17 Jun 2025 | |
| Joseph E. Gilliam |
3/4/5
|
Director |
—
class O/S missing
|
16,129
|
— | — | 17 Jun 2025 |
Institutional Holders of Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) as of Q2 2025
As of 30 Jun 2025,
Caris Life Sciences, Inc. - Common Stock, par value $0.001 per share (CAI) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
109,280,872 shares.
The largest 10 holders included
Sixth Street Partners Management Company, L.P., COATUE MANAGEMENT LLC, FMR LLC, BRAIDWELL LP, T. Rowe Price Investment Management, Inc., PRICE T ROWE ASSOCIATES INC /MD/, NEUBERGER BERMAN GROUP LLC, Silver Lake Group, L.L.C., MILLENNIUM MANAGEMENT LLC, and ORBIMED ADVISORS LLC.
This page lists
115
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q4 2025 Across Filers
Q4 2025 holders
184
Q2 2025 holders
115
Holder diff
-69
| Investor | Q4 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.